Synexa Life Sciences
Matt Goodwin is currently the Business Development Director at Synexa Life Sciences Ltd. Prior to this role, Matt held various positions in business development and sales management at companies such as Labcorp Drug Development and Centre for Process Innovation Limited. Matt has a strong background in biotechnology, with experience in prospecting, new business development, account management, and proposal management. Matt holds a Ph.D. in Electrochromism and a BSc in Biochemistry, Biophysics, and Molecular Biology from The University of Birmingham.
This person is not in any offices
Synexa Life Sciences
Synexa Life Sciences is a global provider of biomarker and bioanalytical services, specialising in the development, validation, and delivery of a wide range of complex and custom-designed assays. With a team of 150 across five global laboratory locations; Cape Town, London, Berlin, Turku (Finland) and Rockville (Maryland USA), we provide innovative solutions to support our customers to achieve their clinical milestones. Our main areas of expertise include biomarker identification and development, clinical bioanalysis, soluble biomarker analysis (utilising MSD, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry and ELISpot) and genomic services to support clinical trials and translational studies. We pride ourselves on our deep scientific expertise and our ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis. We partner with our customers to contribute to the furtherment of scientific development and ultimately better management and treatment of human health. Synexa, improving the quality of human health through innovative biomarker and bioanalytical solutions.